Effects of sample preparation on cyclosporin G (NVA2-cyclosporin) concentration

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

Gynecologic oncology·2006

Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation.

Clinical therapeutics·2000

Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay.

Clinical biochemistry·2000

Minor immunophilin binding of tacrolimus and sirolimus metabolites.

Clinical biochemistry·2000

Pharmacokinetics and metabolism of sirolimus.

Therapeutic drug monitoring·2000

Current opinions on therapeutic drug monitoring of immunosuppressive drugs.

Clinical therapeutics·1999

How to Establish a Reference Interval: A Practical Approach.

Clinical chemistry·2026

Current Evidence for Integrating Mass Spectrometry into Clinical M-Protein Assessment in Plasma Cell Dyscrasias.

Clinical chemistry·2026

Urinary Cell-Free DNA Fragmentomics Detects Multiple Urologic Cancers and May Reduce Unnecessary Prostate Biopsies.

Clinical chemistry·2026

Biomarker Discovery for PMM2-CDG Using Fractionated N-Glycomics Analysis.

Clinical chemistry·2026

Optimal Positive Control Assays for Methylation-Specific PCR.

Clinical chemistry·2026

Clinical Utility and Diagnostic Performance of (1→3)-β-D-Glucan in Invasive Mycoses.

Clinical chemistry·2026

Bioactive constituent profiling of brown sugar and functional evaluation of an isolated oligosaccharide with iron absorption-promoting and anti-anemia effects.

Food & function·2026

Hinge-region Cys-to-Ser mutation enables homogeneous DAR6 anti-c-Met biparatopic ADCs with tolerable O-glycosylation.

Antibody therapeutics·2026

Ultrahigh-DAR antibody-drug conjugates: advancing the next generation of targeted therapy.

Antibody therapeutics·2026

Proximity-Induced Disulfide Rebridging Enables Modular Construction of Stable Antibody-Drug Conjugates.

Angewandte Chemie (International ed. in English)·2026

Drug-in-Cyclodextrin-in-Liposome Hybrid Systems for Hydrophobic Drug Delivery: A Comprehensive Review.

Macromolecular bioscience·2026

Self-assembled micelles of Glycyrrhizic acid and Glabridin: A novel transdermal delivery system with enhanced whitening efficacy.

International journal of pharmaceutics·2026

Related Experiment Videos

Effects of sample preparation on cyclosporin G (NVA2-cyclosporin) concentration

Related Concept Videos

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation.

Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay.

Minor immunophilin binding of tacrolimus and sirolimus metabolites.

Pharmacokinetics and metabolism of sirolimus.

Current opinions on therapeutic drug monitoring of immunosuppressive drugs.

How to Establish a Reference Interval: A Practical Approach.

Current Evidence for Integrating Mass Spectrometry into Clinical M-Protein Assessment in Plasma Cell Dyscrasias.

Urinary Cell-Free DNA Fragmentomics Detects Multiple Urologic Cancers and May Reduce Unnecessary Prostate Biopsies.

Biomarker Discovery for PMM2-CDG Using Fractionated N-Glycomics Analysis.

Optimal Positive Control Assays for Methylation-Specific PCR.

Clinical Utility and Diagnostic Performance of (1→3)-β-D-Glucan in Invasive Mycoses.

Bioactive constituent profiling of brown sugar and functional evaluation of an isolated oligosaccharide with iron absorption-promoting and anti-anemia effects.

Hinge-region Cys-to-Ser mutation enables homogeneous DAR6 anti-c-Met biparatopic ADCs with tolerable O-glycosylation.

Ultrahigh-DAR antibody-drug conjugates: advancing the next generation of targeted therapy.

Proximity-Induced Disulfide Rebridging Enables Modular Construction of Stable Antibody-Drug Conjugates.

Drug-in-Cyclodextrin-in-Liposome Hybrid Systems for Hydrophobic Drug Delivery: A Comprehensive Review.

Self-assembled micelles of Glycyrrhizic acid and Glabridin: A novel transdermal delivery system with enhanced whitening efficacy.

Related Experiment Videos

Effects of sample preparation on cyclosporin G (NVA2-cyclosporin) concentration

Related Concept Videos

Related Articles